Heart Failure
Access to surgery where rheumatic heart disease is endemic a barrier to improving survival
Much of the mortality in rheumatic heart disease was attributable to heart failure, and was significantly reduced by interventional treatment, which may stand as a barrier to improving mortality in lower-income countries, data show.
Top in cardiology: Link between heart health and age; sudden cardiac death among athletes
People who adhere to a heart-healthy lifestyle experience cardiovascular health benefits that may partially be due to the effect of this lifestyle on biological age, according to an analysis in the Journal of the American Heart Association.
Remdesivir in adults with COVID-19 did not reduce major adverse cardiovascular event risk
Use of remdesivir in hospitalized patients with COVID-19 and reduced eGFR did not decrease the risk of major adverse cardiovascular events or major adverse kidney disease.
Potential link seen between heart failure post-hospitalization, kidney disease
In a study of Medicare beneficiaries, researchers from Brigham and Women’s Hospital found that 6% of patients treated for heart failure progressed to dialysis within 1 year after hospitalization.
Regular fish oil use may pose cardiovascular risk in those with no prior CVD
Regular use of fish oil supplements was tied to an increased risk of stroke and atrial fibrillation in adults with no prior CVD, according to results of a large prospective cohort study published in BMJ Medicine.
Hydralazine-induced autoimmune conditions may include drug-induced lupus, vasculitis
LONG BEACH, Calif. — Hydralazine-induced autoimmune conditions may have a varied presentation, including drug-induced lupus or vasculitis, according to a speaker, here.
Active cancer treatment linked to increased risk for sudden cardiac arrest
Active cancer treatment is associated with increased risk for sudden cardiac death, especially among patients younger than 74 years old and those with a history of heart failure, results from a retrospective study showed.
Top in cardiology: GLP-1s beneficial in patients with heart failure, atrial fibrillation
Semaglutide 2.4 mg improved symptoms and physical function in patients with obesity-related heart failure with preserved ejection fraction compared with placebo, regardless of diuretic use, according to new data from the STEP-HFpEF trials.
FDA clears AI algorithm for detection of worsening HF
Implicity announced it received 510(k) clearance from the FDA for its new AI algorithm to assess risk for future HF events from data gathered from various cardiac implantable electronic devices.
Mitral regurgitation linked to heightened risk of CKD in patients with heart failure
LONG BEACH, Calif. — Patients with heart failure who also experienced mitral regurgitation saw a doubling of their creatinine, according to data presented here.